Komori
Earnings7775DAIKEN MEDICAL CO.,LTD.Electrical Equipment and Precision Instruments

Earnings Report for the First Quarter of the Fiscal Year Ending March 2027 [Japanese GAAP] (Non-consolidated)

In the first quarter, revenue declined 2.3% year on year and operating profit fell 23.9%, resulting in lower revenue and profit. In addition to lower sales of suction equipment, a rise in material costs led to a significant decline in profit.

Worth reading
37Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Deterioration
Direction inferred from the company’s description.
Scale
23.9
% (year-on-year decrease in operating profit)
Wording
Conditional
How definitive the wording is.

Results for this period

First quarter1 April 2026 to 30 June 2026Non-consolidated (standalone)Japanese GAAP
Net Sales2,439million yenYear on year -2.3%Progress 23.2%
Operating profit214million yenYear on year -23.9%Progress 25.5%
Ordinary income213million yenYear on year -24.4%Progress 25.8%
Net income attributable to owners of the parent167million yenYear on year -22.3%Progress 28.3%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥5.83
Financial position at period-end
Total assets11,076million yen
of which net assets 7,628 million yenEquity ratio 68.6%vs. prior year-end +0.4pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Outlook and shareholder returns
Full-year earnings forecast
Net Sales10,500 million yen (YoY +2.0%)
Operating profit840 million yen (YoY -34.3%)
Ordinary income825 million yen (YoY -35.3%)
Net income590 million yen (YoY -36.1%)
Annual Dividend Forecast20 yen → 20 yen(0.0%)
Factors Behind Changes in Business Performance

Although sales of クーデックエイミーPCA (PCA infusion pump) remained strong, sales of suction equipment declined year on year. Higher material costs reduced gross profit.

Disclosure regarding the going concern assumption

No applicable matters

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Breakdown of extraordinary income (loss)Extraordinary income Gain on reversal of subscription rights to shares 202 thousand yen / Extraordinary loss Loss on Disposal of Fixed Assets 98 thousand yen
Depreciation and amortization69,562 thousand yen
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End31,840,000 Shares
Treasury Shares at Period-End3,111,563 Shares
Results for this period
ItemDetails
Fiscal Period ClassificationFirst quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedNon-consolidated (standalone)
Period Covered1 April 2026 to 30 June 2026
Net Sales2,439 million yen (YoY -2.3%)
Operating profit214 million yen (YoY -23.9%)
Ordinary income213 million yen (YoY -24.4%)
Profit attributable to owners of the parent167 million yen (YoY -22.3%)
Net income per share¥5.83
Equity ratioEnd of the current fiscal period 68.6% / End of previous period 68.2%
Total assets11,076 million yen
Net assets7,628 million yen
Full-year earnings forecastNet Sales 10,500 million yen (YoY +2.0%) / Operating profit 840 million yen (YoY -34.3%) / Ordinary income 825 million yen (YoY -35.3%) / Net income 590 million yen (YoY -36.1%)
Annual Dividend Forecast20 yen → 20 yen(0.0%)
Depreciation and amortization69,562 thousand yen
Breakdown of extraordinary income (loss)Extraordinary income Gain on reversal of subscription rights to shares 202 thousand yen / Extraordinary loss Loss on Disposal of Fixed Assets 98 thousand yen
Disclosure regarding the going concern assumptionNo applicable matters
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End31,840,000 Shares
Treasury Shares at Period-End3,111,563 Shares
Factors Behind Changes in Business PerformanceAlthough sales of クーデックエイミーPCA (PCA infusion pump) remained strong, sales of suction equipment declined year on year. Higher material costs reduced gross profit.
Items this document does not state (15)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossChanges in the scope of consolidationMaterial subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Although sales of クーデックエイミーPCA (PCA infusion pump) were strong, sales of suction equipment declined year on year, while higher material costs reduced gross profit.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Earnings Report for the First Quarter of the Fiscal Year Ending March 2027 [Japanese GAAP] (Non-consolidated) | DAIKEN MEDICAL CO.,LTD. (7775) timely disclosure | Komori